1. Home
  2. OPK vs NRK Comparison

OPK vs NRK Comparison

Compare OPK & NRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPK
  • NRK
  • Stock Information
  • Founded
  • OPK 2007
  • NRK 2002
  • Country
  • OPK United States
  • NRK United States
  • Employees
  • OPK N/A
  • NRK N/A
  • Industry
  • OPK Biotechnology: Pharmaceutical Preparations
  • NRK Trusts Except Educational Religious and Charitable
  • Sector
  • OPK Health Care
  • NRK Finance
  • Exchange
  • OPK Nasdaq
  • NRK Nasdaq
  • Market Cap
  • OPK 1.0B
  • NRK 824.4M
  • IPO Year
  • OPK 1995
  • NRK N/A
  • Fundamental
  • Price
  • OPK $1.39
  • NRK $9.99
  • Analyst Decision
  • OPK Buy
  • NRK
  • Analyst Count
  • OPK 4
  • NRK 0
  • Target Price
  • OPK $2.75
  • NRK N/A
  • AVG Volume (30 Days)
  • OPK 1.9M
  • NRK 187.3K
  • Earning Date
  • OPK 11-06-2025
  • NRK 01-01-0001
  • Dividend Yield
  • OPK N/A
  • NRK 4.10%
  • EPS Growth
  • OPK N/A
  • NRK N/A
  • EPS
  • OPK N/A
  • NRK N/A
  • Revenue
  • OPK $664,029,000.00
  • NRK N/A
  • Revenue This Year
  • OPK N/A
  • NRK N/A
  • Revenue Next Year
  • OPK $0.84
  • NRK N/A
  • P/E Ratio
  • OPK N/A
  • NRK N/A
  • Revenue Growth
  • OPK N/A
  • NRK N/A
  • 52 Week Low
  • OPK $1.11
  • NRK $8.95
  • 52 Week High
  • OPK $2.04
  • NRK $11.09
  • Technical
  • Relative Strength Index (RSI)
  • OPK 51.88
  • NRK 78.08
  • Support Level
  • OPK $1.34
  • NRK $9.84
  • Resistance Level
  • OPK $1.44
  • NRK $10.00
  • Average True Range (ATR)
  • OPK 0.04
  • NRK 0.07
  • MACD
  • OPK -0.00
  • NRK 0.06
  • Stochastic Oscillator
  • OPK 50.00
  • NRK 93.55

About OPK OPKO Health Inc.

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

About NRK Nuveen New York AMT-Free Quality Municipal Income Fund

Nuveen New York AMT-Free Quality Municipal Income Fund is a closed-end investment company. Its investment objective is to provide current income exempt from regular federal, New York State, and New York City income taxes and from the federal alternative minimum tax applies to individuals and to enhance portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds that the Fund's investment adviser believes are underrated or undervalued or that represent municipal market sectors that are undervalued.

Share on Social Networks: